Correlation of body mass index with toxicity and survival in locoregionally advanced head and neck cancer patients treated with induction chemotherapy and concurrent chemoradiotherapy

被引:0
|
作者
Jain, A. K. [1 ]
Salama, J. K. [1 ]
Stenson, K. M. [1 ]
Blair, E. [1 ]
Cohen, E. E. [1 ]
Witt, M. [1 ]
Haraf, D. J. [1 ]
Vokes, E. E. [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6074
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Nimotuzumab with concurrent chemoradiotherapy in patients with locally advanced head and neck cancer (LASCCHN).
    Somani, Naresh
    Karandikar, S. M.
    Bokil, Kamlesh
    Bhowmik, Kumar Tapash
    Agarwal, Shyam
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Association of Body Mass Index with Survival Outcome in Patients with Head and Neck Cancer Treated with Combined Modality Therapy
    Ma, S. J.
    Khan, M.
    Iovoli, A. J.
    Farrugia, M. K.
    Wooten, K. E.
    Gupta, V.
    Mcspadden, R.
    Kuriakose, M.
    Hicks, W. L.
    Platek, M. E.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E21 - E22
  • [43] Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
    Zhang, Lijuan
    Jiang, Nan
    Shi, Yuexian
    Li, Shipeng
    Wang, Peiguo
    Zhao, Yue
    SCIENTIFIC REPORTS, 2015, 5
  • [44] Impact of metformin on patients with advanced head and neck cancer undergoing concurrent chemoradiotherapy
    Chang, Pei-Hung
    Yeh, Kun-Yun
    Wang, Cheng-Hsu
    Chen, Eric Yen-Chao
    Yang, Shih-Wei
    Chou, Wen-Chi
    Hsieh, Jason Chia-Hsun
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (08): : 1573 - 1577
  • [45] Late toxicity in patients treated with concurrent chemotherapy and radiotherapy for head and neck cancers
    Calais, G
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S71 - S71
  • [46] Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy
    Shah, Bhartesh A.
    Qureshi, Muhammad M.
    Logue, Jennifer M.
    Cooley, Timothy P.
    Zaner, Ken S.
    Jalisi, Scharukh
    Minh Tam Truong
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2017, 38 (04) : 456 - 461
  • [47] Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
    Zhang, Jianyuan
    Chen, Shaojun
    Li, Guisheng
    Zhang, Weihua
    Qin, Tingting
    Yin, Ping
    Huang, Haixin
    Jiang, Hongwei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1087 - 1097
  • [48] Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
    Jianyuan Zhang
    Shaojun Chen
    Guisheng Li
    Weihua Zhang
    Tingting Qin
    Ping Yin
    Haixin Huang
    Hongwei Jiang
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1087 - 1097
  • [49] Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy
    Zhang, Qun
    Wang, Yan
    Liao, Jun-Fang
    Ren, Yu-Feng
    Shen, Guo-Ping
    Niu, Shao-Qing
    Luo, Wei
    JOURNAL OF CANCER, 2019, 10 (17): : 3899 - 3907
  • [50] Outcome of Radiotherapy Alone for Locoregionally Advanced Head and Neck Cancer Patients Unfit for Chemotherapy
    Huang, S.
    Cheng, L.
    Xu, W.
    Waldron, J.
    Bayley, A.
    Kim, J.
    Dawson, L.
    Hope, A.
    Cho, J.
    O'Sullivan, B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S546 - S546